About L2 DIAGNOSTICS LLC
L2 Diagnostics is a translational research company founded in 1998, specializing in the development of novel diagnostic tools, vaccines, and small molecule therapeutics. The company collaborates with multiple universities, pharmaceutical service companies, and is supported by federal agencies and private foundations.
Development of novel diagnostic toolsDiscovery of new vaccinesDevelopment of small molecule therapeuticsMulti-disciplinary research collaborations
Recent Federal Awards
| Award | Agency | Amount | Date |
|---|---|---|---|
| NOVEL DIAGNOSTIC BIOMARKERS DISCOVERY AND VALIDATION FOR MALARIA SBIR PHASE I | Department of Health and Human Services | $300K | |
| THERAPEUTIC VACCINE PLATFORM TO BOOST IMMUNE RESPONSES IN TUBERCULOSIS | Department of Health and Human Services | $599K |
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to L2 DIAGNOSTICS LLC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.